Skip to main content
John Wingard, MD, Oncology, Biltmore Lake, NC

JohnRWingardMD

Oncology • Biltmore Lake, NC

Hematologic Oncology

Professor of Medicine, University Fla College of Medicine

Join to view full profile

Dr. Wingard is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Wingard's full profile

Already have an account?

  • Office

    81 Mountain Drive
    Biltmore Lake, NC 28715
    Phone+1 352-256-4033

Summary

  • Dr. Wingard is Professor of Medicine and Pediatrics, Director of the Bone Marrow Transplant Program, Price Eminent Scholar, and Deputy Director of the University of Florida Health Cancer Center. He received his undergraduate training at Yale University, his medical training at Johns Hopkins University, his residency at University of Tennessee, and has been on the faculty at Johns Hopkins University, Emory University, and now University of Florida for the past 25 years.

    Dr. Wingard has held a number of leadership positions over the years, including co-chair of the Late Effects Working Committee of the Center for International Blood and Marrow Transplant Research, chair of the Steering Committee of the NHLBI/NCI Blood and Marrow Transplant Clinical Trials Network, Chair of the Board of Directors of the National Marrow Donor Program (Be the Match), and member of the Board of Directors of the Foundation for the Accreditation of Cellular Therapies, and he is a past president of the American Society of Blood and Marrow Transplantation. He currently is Chair of the Advisory Committee of the Center for International Blood and Marrow Transplant Research. He has been continuously NIH-funded since 1999. He has published more than 440 articles in peer-reviewed journals, 61 book chapters, and has edited 4 books. In 2018, he was named a Highly Cited Researcher by Clarivate Analytics (top 1% most-cited reports in one’s field during the year of publication).

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1977 - 1978
  • University of Tennessee
    University of TennesseeResidency, Internal Medicine, 1973 - 1977
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1973

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 1997 - 2025
  • NC State Medical License
    NC State Medical License 2023 - 2025
  • GA State Medical License
    GA State Medical License 1991 - 2013
  • MD State Medical License
    MD State Medical License 1977 - 1993
  • TN State Medical License
    TN State Medical License 1974 - 1984
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2021
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Top Doctors: Florida Castle Connolly, 2000

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • How Clean Is the Linen at My Hospital? The Mucorales on Unclean Linen Discovery Study of Large United States Transplant and Cancer Centers  
    Steven A Pergam, Jose Vazquez, Pranatharthi Chandrasekar, Kieren A Marr, Sankar Swaminathan, Michele I Morris, John R Wingard, Lilian Abbo, Sanjay G Revankar, Becky Sm..., Clinical Infectious Diseases
  • Review Vaccinating Donors for Hematopoietic Cell Transplantation: A Systematic Review and Future Perspectives  
    Shahrukh K Hashmi, John R Wingard, ScienceDirect

Abstracts/Posters

  • Impact of Renal Dysfunction Measured By Estimated Glomerular Filtration Rate (eGFR) on Outcomes after Allogeneic Hematopoietic Cell Transplantation (HCT)
    John R. Wingard, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Diet Quality of Long-Term Allogeneic and Autologous Stem Cell Transplant (HCT) Survivors
    John R. Wingard, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Weighty Choices: Selecting Optimal G-CSF Doses for Stem Cell Mobilization to Optimize Yield 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Other

Press Mentions

  • New Leaders at ASTCT and CIBMTR Provide Guidelines and Measures for Combating COVID-19 and Protecting Transplant Patients
    New Leaders at ASTCT and CIBMTR Provide Guidelines and Measures for Combating COVID-19 and Protecting Transplant PatientsJune 1st, 2020
  • One of the Best: UF Health Cancer Center Earns NCI Designation
    One of the Best: UF Health Cancer Center Earns NCI DesignationJune 21st, 2023

Grant Support

  • Core Clinical Consortium For Blood And Marrow Transplant Clinical Trials NetworkNational Heart, Lung, And Blood Institute2011
  • Core Clinical Center For BMT Clinical Research NetworkNational Heart, Lung, And Blood Institute2001–2010
  • Core--Clinical ResourceNational Institute Of Allergy And Infectious Diseases2007–2008
  • Core--Clinical ResourceNational Institute Of Allergy And Infectious Diseases2004–2007
  • Quality Of Life And Relationships After BMTNational Cancer Institute1999–2001

Professional Memberships

Dr. John Wingard, Dr. John Wingard, MD, Dr. J Wingard, Dr. John R Wingard